SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
333Wedbush says that the 68 PT is derived from 20*2017eps discounted at 15%. I havIRWIN JAMES FRANKEL-12/12/2013
332GENT Wedbush raises PT to 68 on good abstracts at ASH, one will aid in getting UIRWIN JAMES FRANKEL-12/11/2013
331Interim Results from Gentium’s Treatment IND for Defibrotide and additional DataIRWIN JAMES FRANKEL-12/11/2013
330I haven't searched but I wonder if the difference in the percentage of relatghmm-11/26/2013
329Abstracts: ash.confex.com Conclusions: DF therapy in sVOD/MOF pts achieved sigIRWIN JAMES FRANKEL-11/26/2013
328Tue, Nov 26, 2013, 7:07AM EST - US Markets open in 2 hrs and 23 mins IRWIN JAMES FRANKEL-11/26/2013
327Gentium Receives EMA Orphan Drug Designation for Defibrotide for the Prevention IRWIN JAMES FRANKEL-11/19/2013
326Looks like FMR added (filing as of 11/12) another 399,667 shares after 9/30 brinIRWIN JAMES FRANKEL-11/19/2013
325Revision - one new buyer showed up with 45K: Institutional holdings looks closeIRWIN JAMES FRANKEL-11/18/2013
324Institutional holdings looks close to complete: nasdaq.com Overall looks like IRWIN JAMES FRANKEL-11/15/2013
323Institutional holdings coming in Blackrock dumped 3.1M Westfield bought 1.4M CIRWIN JAMES FRANKEL-11/14/2013
322Defibrotide Granted Orphan Drug Status in Australia [graphic] Gentium S.p.A.50 IRWIN JAMES FRANKEL-11/14/2013
32111/13/2013 @ 6:00AM 786 viewsLittle Companies With Big Catalysts This story appeIRWIN JAMES FRANKEL-11/14/2013
320The VPHM buyout is instructive on value of orphan drugs. I owned Lev PharmaceuIRWIN JAMES FRANKEL-11/11/2013
319From Motley Fool today: A parabolic problem It has also been a year to rememberIRWIN JAMES FRANKEL-11/7/2013
318seekingalpha.com FV $68 Buyout value ~$100 This guy has been the catalyst forIRWIN JAMES FRANKEL-11/1/2013
317Brean uses 50,000 euros, and Wedbush 48,000 euros. Wedbush earnings projectionsIRWIN JAMES FRANKEL110/31/2013
316What are the pricing assumptions that underpin those EPS forecasts?DewDiligence_on_SI-10/31/2013
315Wedbush PT 55 2016 EPS $5.49 2017 EPS $7.83IRWIN JAMES FRANKEL-10/31/2013
314FDA resubmission in 1H2014, slipping back as they work on getting better data frIRWIN JAMES FRANKEL-10/31/2013
313Gentium Reports Third Quarter 2013 Financial Results [graphic]Press Release: GenIRWIN JAMES FRANKEL-10/31/2013
312But for the market action leading up to this, I would have thought this would beIRWIN JAMES FRANKEL-10/30/2013
311Tomorrow a.m. should be interesting. I'll walk the dog early.tom pope-10/30/2013
310Earlier by over 2 weeks vs last year: Gentium to Report Third Quarter 2013 FiIRWIN JAMES FRANKEL-10/28/2013
309Wedbush falling behind. :-)IRWIN JAMES FRANKEL-10/24/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News